HOME › DRUGS › DARATUMUMAB AND HYALURONIDASE-FIHJ
ACTIVE SUBSTANCE / INN

DARATUMUMAB AND HYALURONIDASE-FIHJ

Brand name(s): DARZALEX FASPRO
FDA LISTED
PRESCRIPTION
BLA761145
ACTIVE SUBSTANCE
Daratumumab And Hyaluronidase-Fihj
REGULATORS
FDA
SPONSORS / MAH
JANSSEN BIOTECH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DARZALEX FASPROBLA761145JANSSEN BIOTECHPrescription

FULL INTELLIGENCE ON DARATUMUMAB AND HYALURONIDASE-FIHJ

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →